News

Oxford Brain Diagnostics releases Beta version software tool to interpret MRI images for brain degradation analysis (FDA breakthrough device designation)

Published on: 26/07/2021

Oxford Brain Diagnostics releases Beta version software tool to interpret MRI images for brain degradation analysis (FDA breakthrough device designation)
Member News

Oxford Brain Diagnostics is currently developing a new software tool (beta version) for the interpretation of MRI images, pulling together current methods (like brain atrophy) with a new measure that analyses brain degradation at a cellular level. 

The company is looking for clinicians (neurologists, old age psychiatrists, radiologists) interested in learning about this novel way of diagnosis that can predict transition from MCI to Alzheimer’s Disease, and has received FDA breakthrough device designation. 

Discover More

Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.

For more information please contact Daniel Kaute, Daniel.kaute@oxfordbraindiagnostics.com

NEWS​

Related News

InnoHSupport Open Calls

11 Feb 2025
Welcome to the InnoHSupport Open Calls!

Healthcare AI Solutions

6 Feb 2025
The UK government has launched a £150 million procurement drive for artificial intelligence solutions that can be used by the NHS in areas like medica...

Women Entrepreneurship Bootcamp

6 Feb 2025
Welcome to EIT Health Women Entrepreneurship Bootcamp – a customised experience crafted exclusively for you.  

MedTech Bootcamp

6 Feb 2025
EIT Health’s MedTech Bootcamp has been exclusively crafted for trailblazers like you to help you get a clear and valid proof of concept for your idea.

Empowering AI Innovations to Transform Lives: GSMA Launches New Innovation Fund for Startups

6 Feb 2025
The GSMA Innovation Fund is offering grants of up to £250,000 and tailored venture-building support for enterprises using AI and emerging technologies...

Co-Creating the Future of Clinical Data: Join Digital Health Nation Challenge

5 Feb 2025
Join the “Improving clinical data capture for better healthcare outcomes” open innovation call, 5 Feb - 21 March, 2025, to explore the challenge of in...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *